WeightWatchers CEO Sima Sistani out in abrupt exit, embraced weight loss drugs
WeightWatchers announced Friday that CEO Sima Sistani is no longer at the company, and independent board member Tara Comonte has stepped in to serve as interim CEO.
WeightWatchers CEO suddenly quits after push to embrace weight-loss drugs like Ozempic, Wegovy
Sima Sistani, who took up the CEO post at WW International two-and-a-half years ago, is out, according to the company.
Weight loss drugs like Ozempic and Wegovy are tremendously popular and effective. Patients should also be careful in using them
Semaglutide, the underlying drug marketed as Ozempic and Wegovy, works by mimicking a hormone that triggers the body to feel full. When the drug interacts with a receptor in the stomach, patients feel full sooner and for a longer period of time after eating. The drug does not cause weight loss directly – instead, it makes you want to eat less.
What is 'Ozempic face'? How we refer to weight-loss side effects matters.
The term "Ozempic face" is not a medical term, but some use it to describe this type of appearance after weight loss. Here what's fact and fiction.
Weight-loss drugs are supposed to be forever. Until they run out.
Maez Waibel lost more than 30 pounds in nine months on the new weight-loss drugs, sparking a substantial improvement in health. But instead of feeling happy and relieved, Waibel’s days have been freighted with a different emotion: anxiety.
What are Ozempic and Wegovy, the weight loss drugs everyone is talking about?
Although not available in India in injectible form, new weight loss drugs Ozempic and Wegovy are all the rage. Lounge speaks to doctors about these ‘game-changers’
Ozempic maker to testify before Senate committee on weight loss drug prices
Novo Nordisk CEO Lars Fruergaard Jørgensen is testifying before the Senate Health, Education, Labor and Pension committee on Tuesday.
WeightWatchers is struggling in the weight loss drug era — and now the CEO is out
International said Friday that CEO Sima Sistani is stepping down immediately. She will be replaced by Tara Comonte, a board member and the former CEO of Shake Shack (SHAK), who was appointed as interim chief executive effective immediately.
WeightWatchers' CEO embraced Ozempic. Now she's out of the company.
Sima Sistani helped push the company into the GLP-1 drug space with the $106 million acquisition of Sequence.
Are new frozen meals for weight-loss drugs worth it?
Nestle launched frozen meals tailored for people on weight-loss drugs like Ozempic and Wegovy. We tried the teriyaki chicken ...
7 Mistakes People Make While Taking Weight Loss Drugs, According to Experts
GLP-1 medications—like Ozempic, Wegovy, and Zepbound—can help you shed pounds, but only if taken properly. Don't get caught ...
Healthy Returns: Weight loss drug Wegovy could face Medicare price negotiations next
Novo Nordisk's weight loss drug Wegovy could face Medicare price negotiations next. Meanwhile, Particle Health files an ...
What to Eat (& Not to Eat) When Taking Wegovy for Weight Loss
Wegovy is a once-weekly injection approved by the U.S. Food and Drug Administration (FDA) to treat obesity in people 12 and ...
Weight loss injections boom
An emerging market for compounded weight loss injections that mimic brand-name drugs such as Ozempic, Wegovy, Mounjaro and ...
Atlanta Journal-Constitution2d
Amid questions over cost of weight loss shots, Atlanta doctors offer cheaper options
Sen. Bernie Sanders grilled the maker of Wegovy and Ozempic on why the drugs cost so much more in the U.S. than in European countries.
EXCLUSIVE: Novo Nordisk Faces Political Heat Over Weight-Loss Drug Prices Ahead Of Elections, Yet 'The Real Issue Is With The Middlemen'
Novo Nordisk under political pressure over high U.S. drug prices as CEO testifies before Congress. PBMs and limited impact on ...
While brand-name weight loss drugs are in short supply, a market for alternatives thrives
High demand for weight-loss and diabetes drugs like Ozempic and Wegovy has led to a shortage in manufacturing. In the ...